Biodexa Pharmaceuticals Statistics
Total Valuation
BDRX has a market cap or net worth of $180,931. The enterprise value is -$6.62 million.
| Market Cap | 180,931 |
| Enterprise Value | -6.62M |
Important Dates
The next estimated earnings date is Tuesday, April 30, 2024, before market open.
| Earnings Date | Apr 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BDRX has 236,511 shares outstanding. The number of shares has increased by 8,714.17% in one year.
| Shares Outstanding | 236,511 |
| Shares Change (YoY) | +8,714.17% |
| Shares Change (QoQ) | +1,802.61% |
| Owned by Insiders (%) | 10.26% |
| Owned by Institutions (%) | 19.54% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.38 |
| Forward PS | n/a |
| PB Ratio | 0.03 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.10.
| Current Ratio | 1.26 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -181.56 |
Financial Efficiency
Return on equity (ROE) is -180.60% and return on invested capital (ROIC) is -155.85%.
| Return on Equity (ROE) | -180.60% |
| Return on Assets (ROA) | -88.10% |
| Return on Capital (ROIC) | -155.85% |
| Revenue Per Employee | $17,862 |
| Profits Per Employee | -$331,880 |
| Employee Count | 27 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -501,451 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.46% in the last 52 weeks. The beta is 1.57, so BDRX's price volatility has been higher than the market average.
| Beta (1Y) | 1.57 |
| 52-Week Price Change | -96.46% |
| 50-Day Moving Average | 1.21 |
| 200-Day Moving Average | 3.30 |
| Relative Strength Index (RSI) | 35.91 |
| Average Volume (30 Days) | 2,124,622 |
Short Selling Information
The latest short interest is 66,761, so 28.23% of the outstanding shares have been sold short.
| Short Interest | 66,761 |
| Short Previous Month | 102,627 |
| Short % of Shares Out | 28.23% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, BDRX had revenue of $482,278 and -$8.96 million in losses. Loss per share was -$9.88.
| Revenue | 482,278 |
| Gross Profit | 470,574 |
| Operating Income | -9.90M |
| Pretax Income | -9.24M |
| Net Income | -8.96M |
| EBITDA | -8.85M |
| EBIT | -9.19M |
| Loss Per Share | -$9.88 |
Balance Sheet
The company has $7.37 million in cash and $573,087 in debt, giving a net cash position of $6.80 million or $28.76 per share.
| Cash & Cash Equivalents | 7.37M |
| Total Debt | 573,087 |
| Net Cash | 6.80M |
| Net Cash Per Share | $28.76 |
| Equity / Book Value | 5.78M |
| Book Value Per Share | 24.43 |
| Working Capital | 1.80M |
Cash Flow
In the last 12 months, operating cash flow was -$9.47 million and capital expenditures -$27,172, giving a free cash flow of -$9.50 million.
| Operating Cash Flow | -9.47M |
| Capital Expenditures | -27,172 |
| Free Cash Flow | -9.50M |
| FCF Per Share | -$13.67 |
Margins
Gross margin is 97.57%, with operating and profit margins of -2,052.36% and -1,858.01%.
| Gross Margin | 97.57% |
| Operating Margin | -2,052.36% |
| Pretax Margin | -1,916.89% |
| Profit Margin | -1,858.01% |
| EBITDA Margin | -1,834.68% |
| EBIT Margin | -1,906.39% |
| FCF Margin | -1,970.16% |
Dividends & Yields
BDRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8,714.17% |
| Shareholder Yield | -8,714.17% |
| Earnings Yield | -4,952.58% |
| FCF Yield | -5,251.52% |
Analyst Forecast
The average price target for BDRX is $8.00, which is 945.75% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 945.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 5, 2023. It was a reverse split with a ratio of 1:80.
| Last Split Date | Jul 5, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:80 |
Scores
BDRX has an Altman Z-Score of -21.34 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -21.34 |
| Piotroski F-Score | 2 |